[Form 4] PRECISION OPTICS CORPORATION, INC. Insider Trading Activity

Rhea-AI Filing Summary

Precision Optics Corporation, Inc. (POCI) reported a new equity award to a director on a Form 4. The filing shows a grant of stock options to purchase 30,000 shares of common stock at an exercise price of $4.33 per share on 11/17/2025, reported as an acquisition of derivative securities held directly.

The options expire on 11/17/2035 and were granted under the company’s 2022 Equity Incentive Plan. They vest in four equal installments on December 30, 2025, March 30, 2026, June 29, 2026, and September 29, 2026, conditioned on the director’s continuous service with the company through each applicable vesting date.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Pellegrino Joseph P JR

(Last) (First) (Middle)

C/O PRECISION OPTICS CORPORATION,INC.

22 EAST BROADWAY

(Street)

GARDNER MA 01440

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PRECISION OPTICS CORPORATION, INC. [ POCI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (Rights to buy)	$4.33	11/17/2025		A		30,000		(1)	11/17/2035	Common Stock	30,000	$0	30,000	D

Explanation of Responses:

1. The options vest in four equal installments on December 30, 2025, March 30, 2026, June 29, 2026, and September 29, 2026, subject to the reporting person remaining in the continuous employment of the Issuer through such applicable date. The options were granted under the Precision Optics Corporation, Inc. 2022 Equity Incentive Plan.

	/s/ Joseph N. Forkey as attorney-in-fact	11/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Precision Optics (POCI) report in this Form 4 filing?

The filing reports a grant of stock options to a company director, documenting the acquisition of 30,000 derivative securities related to Precision Optics common stock.

How many stock options were granted to the Precision Optics (POCI) director?

The director was granted 30,000 stock options, each representing the right to purchase one share of Precision Optics common stock.

What is the exercise price and expiration date of the POCI stock options?

The stock options have an exercise price of $4.33 per share and an expiration date of 11/17/2035.

How do the Precision Optics (POCI) director options vest?

The options vest in four equal installments on December 30, 2025, March 30, 2026, June 29, 2026, and September 29, 2026, if the director remains in continuous employment with the company through each date.

Under which plan were the POCI stock options granted?

The options were granted under the Precision Optics Corporation, Inc. 2022 Equity Incentive Plan, as stated in the explanation of responses.

Is the director’s ownership in POCI reported as direct or indirect?

The filing indicates that the 30,000 stock options are held with direct ownership by the reporting person.